Stocks · Healthcare · Medical - Specialties

Spectral AI, Inc. MDAI

$1.66 +0.00% Close, Oct 2, 2026 · NASDAQ · Market cap $52.8M

Next earnings report: Nov 10, 2026

Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.

Three things to know

  1. Operating margin narrowed to -79.9% from -18.2% a year earlier.
  2. The diluted share count rose 26.2% in a year.
  3. Revenue over the last four quarters was $15.2M, down 45.0% from a year earlier.

PromtFinance scores

Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.

Growth9Very weak

How fast revenue, earnings and cash flow are growing.

  • Revenue growth (TTM, YoY)Bottom 12%
  • Revenue growth, 3-year CAGRBottom 13%
  • Revenue growth accelerationBottom 45%
Quality4Very weak

Returns on capital, margins, earnings quality and balance-sheet strength.

  • Return on invested capitalBottom 2%
  • Gross marginBottom 27%
  • Operating marginBottom 31%
  • Accruals (lower is better)Bottom 6%
  • Interest coverBottom 35%
Value33Weak

How cheap the shares are relative to earnings, cash flow and their own history.

  • Earnings yieldBottom 31%
  • Free-cash-flow yieldBottom 21%
  • EBITDA / enterprise valueBottom 31%
  • Sales / enterprise valueTop 45%
Momentum35Weak

Strength and persistence of the price trend, including versus the S&P 500.

  • 12-month return excluding last monthBottom 16%
  • 6-month returnTop 44%
  • 1-year return vs S&P 500Bottom 24%
  • Distance from 52-week highBottom 35%
  • Trend checklist (0–4)Top 39%
Revisions51Neutral

Earnings surprises and analyst sentiment (estimate-revision history is being collected).

  • Average EPS surprise, last 4 quartersBottom 29%
  • Consecutive EPS beatsBottom 49%
  • Upside to consensus price targetTop 29%
Stability60Neutral

Low volatility, shallow drawdowns, low market sensitivity and modest leverage.

  • Volatility, 60 days (lower is better)Top 28%
  • Maximum drawdown, 3 yearsBottom 44%
  • Beta vs S&P 500 (lower is better)Bottom 49%

What changed

Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).

MeasureBeforeNow
Revenue growth (YoY)-44.3%-45.0%↓
Gross margin45.3%41.5%↓
Operating margin-18.2%-79.9%↓
FCF margin-21.9%-85.0%↓

Fundamental momentum

MeasureNow (TTM)Year / quarter beforeSector rank
Revenue growth (TTM, YoY)-45.0%-44.3%↓Bottom 12%
Gross margin41.5%45.3%↓Bottom 27%
Operating margin-79.9%-18.2%↓Bottom 31%
Net margin-69.3%-52.0%↓—
Free-cash-flow margin-85.0%-21.9%↓—
Return on invested capital-288.4%—Bottom 2%
Revenue growth, 3-year CAGR-8.2%—Bottom 13%

Quality of earnings and balance sheet

Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
12.2%
Stock-based compensation / revenueA cost to shareholders through dilution.
9.9%
Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
+25.5 pp
Interest cover (operating income / interest)How many times operating profit covers interest.
-8.1×

Shareholder returns

Dividend yield (dividends paid, TTM)
0.00%
Net buyback yield (TTM)
-19.71%
Shareholder yield
-19.71%
Share count change, 1 year
+26.2%
Share count change, 3-year CAGR
+21.5%

Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.

Based on the four quarters through Jun 30, 2026 (filed Aug 11, 2026).

Earnings and expectations

Earnings momentum

Consecutive EPS beats
1
Beats in the last 8 reports
4 of 8
Average EPS surprise, last 4
-10.2%
Average 2-day reaction, last 8
-4.2%
Positive 20 days after report
3 of 8

Analysts

Consensus price target
$4.00
Target vs current price
+141.0%

How the stock reacted to recent reports

Report dateEPS surprise2 days5 days20 days60 days
Aug 11, 2026+3.7%+0.0%-4.1%-5.8%—
May 12, 2026+0.0%-7.7%-3.9%-20.2%-28.8%
Mar 24, 2026+8.3%-4.1%-15.1%+4.1%+5.2%
Nov 11, 2025-52.9%-5.5%-20.9%-5.5%-16.5%
Aug 12, 2025-342.9%-5.5%-10.2%-21.2%-16.5%
May 14, 2025+210.0%-8.5%-4.2%+44.4%+71.8%
Mar 27, 2025-215.4%-4.5%-3.7%-5.2%+53.0%
Nov 6, 2024+42.9%+2.0%-8.8%+46.6%+26.4%

Returns from the close before each report. Past reactions do not determine future ones.

Earnings history

Report dateEPSEstimateSurpriseRevenue
Aug 11, 2026-$0.13-$0.14+3.7%$3.5M
May 12, 2026-$0.11-$0.11+0.0%$4.0M
Mar 24, 2026-$0.11-$0.12+8.3%$3.8M
Nov 11, 2025-$0.13-$0.09-52.9%$3.8M
Aug 12, 2025-$0.31-$0.07-342.9%$5.1M
May 14, 2025$0.11-$0.10+210.0%$6.7M
Mar 27, 2025-$0.41-$0.13-215.4%$7.6M
Nov 6, 2024-$0.08-$0.14+42.9%$8.2M

Valuation in context

MultipleNow5-year median5-year percentileSector rank (cheapness)
EV / Sales3.64×——Top 45%
Free-cash-flow yield-24.38%——Bottom 21%
Earnings yield-21.02%——Bottom 31%

Technical state

Trend checklist

  • ✓ Price above 20-day average
  • ✓ Price above 50-day average
  • ✗ Price above 200-day average
  • ✗ 50-day average above 200-day
  • ✓ MACD histogram positive

Trend quality

Days above the 50-day average
3
Days above the 200-day average
0
50-day average slope (20 days)
-2.3%
200-day average slope (20 days)
+0.3%
Distance from 50-day average
+2.8%
Distance from 200-day average
-2.3%
RSI (14)
55.4
Relative volume
1.58×

Risk and drawdowns

Volatility, 60 days (annualized)
44.2%
Volatility vs own 5-year history
34th percentile · Normal for this stock
Beta vs S&P 500 (2 years, weekly)
1.13
Correlation with S&P 500
0.19
Current drawdown from 1-year high
-38.1%
Maximum drawdown, 3 years
-74.0%

Largest declines in the past six years

From peakTo lowDeclineLengthRecovery
Sep 7, 2023Sep 24, 2024-93.5%263 daysNot yet recovered
Apr 14, 2023Aug 30, 2023-29.4%95 days5 days (Sep 7, 2023)

Declines of 10% or more from a closing high, measured on daily closes.

Financial statements

Market cap
$52.8M
EPS, diluted (TTM)
-$0.35
Revenue (TTM)
$15.2M
52-week range
$1.18 – $2.97
FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$15.2M$25.4M$18.1M$29.6M$19.6M
Gross profit$7.1M$10.8M$7.9M$13.3M$8.9M
Operating income-$4.2M-$2.6M-$13.0M-$6.6M-$8.6M
Net income-$4.0M-$2.9M-$20.9M-$15.3M-$7.6M
EPS (diluted)-$0.33-$0.16-$1.48-$0.85-$0.29
Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Revenue$8.2M$7.6M$6.7M$5.1M$3.8M$3.8M$4.0M$3.5M
Net income-$1.5M-$7.7M$2.9M-$8.0M-$3.6M$642,000-$3.4M-$4.2M
EPS (diluted)-$0.08-$0.41$0.11-$0.31-$0.13$0.02-$0.11-$0.13
FY 2021FY 2022FY 2023FY 2024FY 2025
Operating cash flow-$2.9M-$1.2M-$13.2M-$9.2M-$9.9M
Capital expenditure-$7,000$0$0$0$0
Free cash flow-$2.9M-$1.2M-$13.2M-$9.2M-$9.9M
Dividends paid$0$0$0$0$0
Net share buybacks$14.6M$0$3.4M$4.1M$13.4M

Cash outflows are shown as negative numbers.

Cash and short-term investments
$14.0M
Total assets
$19.4M
Total liabilities
$31.5M
Total debt
$16.3M
Net debt
$2.3M
Shareholders’ equity
-$12.1M

As of Jun 30, 2026 (filed Aug 11, 2026).

Short interest

Shares sold short
2,195,305
Days to cover
21.88
Change vs previous report
-1.8%

FINRA short interest, settlement date Sep 15, 2026.